BRAF and neoplasm: The analysis assessed ORR and PFS based on factors including PD-L1 expression, RAS/BRAF mutation status, primary tumor characteristics, TGF-β1 levels, pSMAD2/3 expression, and lactate dehydrogenase (LDH) levels.